The trial results of a three-drug combination called PaMZ, unveiled at the International Aids Conference in Melbourne last month, offer hope of the first new medication in half a century for the widespread treatment of tuberculosis - and one which also has the potential to cure multi-drug-resistant TB.

At a talk hosted in London by the University of Cape Town Trust, Professor Kelly Chibale discussed his team's breakthrough in the fight against malaria, inspired by the motto 'Finding African solutions to African problems.'